|
|
||||||||
1Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8558; 2Division of Nephrology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki 701-01; and 3Department of Medicine II, Kansai Medical School, Osaka 570-8506, Japan
Submitted 21 August 2003 ; accepted in final form 20 October 2003
Angiotensin II mediates the progression of renal disease through the type 1 receptor (AT1R). Recent studies have suggested that type 2 receptor (AT2R)-mediated signaling inhibits cell proliferation by counteracting the actions of AT1R. The aim of the present study was to determine the effect of AT2R overexpression on glomerular injury induced by
nephrectomy (
Nx). AT2R transgenic mice (AT2-Tg), overexpressing AT2R under the control of
-smooth muscle actin (
-SMA) promoter, and control wild-type mice (Wild) were subjected to
Nx. In AT2-Tg mice, the glomerular expression of AT2R was upregulated after
Nx. Urinary albumin excretion at 12 wk after
Nx was decreased by 33.7% in AT2-Tg compared with Wild mice. Glomerular size in AT2-Tg mice was significantly smaller than in Wild mice after
Nx (93.1 ± 3.0 vs. 103.3 ± 1.8 µm; P < 0.05). Immunohistochemistry revealed significant decreases in glomerular expression of platelet-derived growth factor-BB chain (PDGF-BB) and transforming growth factor-
1 (TGF-
1) in AT2-Tg with
Nx compared with Wild mice. Urinary excretion of nitric oxide metabolites was increased 2.5-fold in AT2-Tg compared with Wild mice. EMSA showed that activation of early growth response gene-1, which induces the transcription of PDGF-BB and TGF-
1, was decreased in AT2-Tg mice. These changes in AT2-Tg mice at 12 wk after
Nx were blocked by the AT2R antagonist PD-123319. Taken together, our findings suggest that AT2R-mediated signaling may protect from glomerular injuries induced by
Nx and that overexpression of AT2R may serve as a potential therapeutic strategy for glomerular disorders.
angiotensin II receptor; angiotensin II; transgenic mouse; nitric oxide
This article has been cited by other articles:
![]() |
R. S. Lindoso, K. S. Verdoorn, and M. Einicker-Lamas Renal recovery after injury: the role of Pax-2 Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2628 - 2633. [Full Text] [PDF] |
||||
![]() |
C. M. Coleman, J. J. Minor, L. E. Burt, B. A. Thornhill, M. S. Forbes, and R. L. Chevalier Angiotensin AT1-receptor inhibition exacerbates renal injury resulting from partial unilateral ureteral obstruction in the neonatal rat Am J Physiol Renal Physiol, July 1, 2007; 293(1): F262 - F268. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Benigni, D. Corna, C. Zoja, L. Longaretti, E. Gagliardini, N. Perico, T. M. Coffman, and G. Remuzzi Targeted Deletion of Angiotensin II Type 1A Receptor Does not Protect Mice from Progressive Nephropathy of Overload Proteinuria J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2666 - 2674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |